PROVIDER PROFILE · NPI 1376513812
Enrico VillanuevaM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
570
Unique beneficiaries
—
Total services
5,991
Distinct HCPCS
8
Medicare payment
$210K
Peer benchmark
Total Medicare services vs. 133 Rheumatology providers in MD — above median (cohort median 27,542).
PRESCRIBING · PART D · 2024
Total Rx claims
1,123
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
17
Brand share
37.8%
Top prescribed drugs
Prednisone321 claims
Methotrexate Sodium223 claims
Hydroxychloroquine Sulfate99 claims
Etanercept74 claims
Allopurinol55 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
111
By payment type
Food and Beverage$2K
Education$84
Top paying entities
Food and Beverage$2K
Education$84
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Enrico Villanueva's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 28 | 60 |
| CRESCENDO BIOSCIENCE, INC | 13 | 14 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC | 123 | 249 |
| Meritus Medical Laboratory Llc Clinical Laboratory · Hagerstown, MD | 64 | 163 |
| FREDERICK HEALTH HOSPITAL INC | 49 | 129 |
| Jill Wilkens Diagnostic Radiology · Owings Mills, MD | 19 | 29 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 17 | 30 |
| MERITUS MEDICAL CENTER INC | 15 | 25 |
| Pamela Bradford Internal Medicine · Waynesboro, PA | 14 | 37 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE